SGN Launches New Opportunities and Look
SGN Nanopharma is pleased to announce updates to its drug reformulation strategy and entry into the research of NanoCannabinoids. Find out more at the all-new website at www.sgn.bio
US Transdermal Patch Market & Clinical Trial Insight
LONDON, Dec. 18, 2016 /PRNewswire/ — Innovations in pharmaceutical industry have a long track record of showing commercialization potential with respect to emerging and feasible technology. In US, such innovations have high level of acceptance among various stake holders of the pharmaceutical industry. Transdermal patches have emerged as one such innovations which have rich history
Transdermal drug delivery looks for new frontiers
Microneedles and ‘active’ patches extend the reach of transdermal applications